US Patent Issued to Vail Scientific on Feb. 3 for "Apparatus and method for the determination of endothelial dysfunction and sepsis risk using nitric oxide concentrations in exhaled breath" (Minnesota Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,073, issued on Feb. 3, was assigned to Vail Scientific Inc. (Inver Grove Heights, Minn.).

"Apparatus and method for the determination of endothelial dysfunction and sepsis risk using nitric oxide concentrations in exhaled breath" was invented by Carter R. Anderson (Inver Grove Heights, Minn.), Russell L. Morris (Lindstrom, Minn.), Thomas W. Burke (Plymouth, Minn.) and Clayton J. Anderson (Lakeville, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for determining a risk of sepsis in a patient is disclosed. The method includes collecting an exhaled breath sample, determining a NO concentration in the exhaled breath sample; and determining...